Table 5.
Hazard ratio of Discharge in Immunocompromised vs Nonimmunocompromised Adults Hospitalized With Laboratory-confirmed Influenza In the US Influenza Hospitalization Surveillance Network, 2011–2015
aHR of Discharge | 95% CI | |
---|---|---|
Primary analysisa | 0.86 | .83–.88 |
Sensitivity analysisa,b | 0.87 | .84–.89 |
Abbreviations: aHR, adjusted hazard ratio; CI, confidence interval.
aControlling for age, sex, race/ethnicity, influenza vaccination, underlying medical conditions (smoking, obesity, chronic lung disease, cardiovascular disease, chronic metabolic disease, neuromuscular disorders, neurologic disorders, renal disease, liver disease), antiviral use, and influenza season.
bIncluding receipt of steroid therapy in the immunocompromised group.